MOTS-C is a mitochondrial-derived research peptide studied in preclinical research for its potential effects on metabolism, energy regulation, and cellular health. Preclinical research suggests it may enhance mitochondrial function, improve exercise capacity, and support glucose metabolism. Studies have also explored its potential role in reducing metabolic stress, promoting fat utilization, and improving overall cellular resilience.
For research use only — not for human consumption, medical, or therapeutic use.
